President & CEO of Illumina, Inc. (
ILMN) Jay T Flatley sells 5,000 shares of ILMN on 01/24/2013 at an average price of $50.91 a share.
Illumina, Inc. has a market cap of $6.42 billion; its shares were traded at around $51.94 with a P/E ratio of 74.9 and P/S ratio of 6.1.
CEO Recent Trades:
- President & CEO Jay T Flatley sold 5,000 shares of ILMN stock on 01/24/2013 at the average price of 50.91. Jay T Flatley owns at least 409,357 shares after this. The price of the stock has increased by 2.02% since.
- President & CEO Jay T Flatley sold 5,000 shares of ILMN stock on 01/10/2013 at the average price of 52.93. Jay T Flatley owns at least 409,357 shares after this. The price of the stock has decreased by 1.87% since.
- President and CEO Jay T Flatley sold 10,000 shares of ILMN stock on 12/27/2012 at the average price of 55.53. Jay T Flatley owns at least 409,357 shares after this. The price of the stock has decreased by 6.46% since.
- President & CEO Jay T Flatley sold 5,000 shares of ILMN stock on 12/13/2012 at the average price of 52.74. Jay T Flatley owns at least 409,357 shares after this. The price of the stock has decreased by 1.52% since.
- President & CEO Jay T Flatley sold 5,000 shares of ILMN stock on 11/23/2012 at the average price of 53.32. Jay T Flatley owns at least 409,357 shares after this. The price of the stock has decreased by 2.59% since.
Directors and Officers Recent Trades:
- Sr VP & General Manager Mark L Lewis sold 24,500 shares of ILMN stock on 12/20/2012 at the average price of 56.21. Mark L Lewis owns at least 41,885 shares after this. The price of the stock has decreased by 7.6% since.
- Sr VP & General Manager Mark L Lewis sold 5,000 shares of ILMN stock on 12/19/2012 at the average price of 51.87. Mark L Lewis owns at least 41,885 shares after this. The price of the stock has increased by 0.13% since.
- Sr VP & GM Molecular Biology Mark L Lewis sold 5,000 shares of ILMN stock on 11/19/2012 at the average price of 50. Mark L Lewis owns at least 41,885 shares after this. The price of the stock has increased by 3.88% since.
- Sr VP, General Manager Genomic Christian O Henry sold 10,000 shares of ILMN stock on 10/09/2012 at the average price of 51.7. Christian O Henry owns at least 37,745 shares after this. The price of the stock has increased by 0.46% since.
- Sr VP, General Manager Genomic Christian O Henry sold 30,000 shares of ILMN stock on 09/14/2012 at the average price of 48. Christian O Henry owns at least 37,745 shares after this. The price of the stock has increased by 8.21% since.
For the complete insider trading history of ILMN,
click here.
European Shorting
Feedback
My Portfolios
Browse Gurus
RSS